Effects of the Antithrombotic Drug Suloctidil on Low Density Lipoprotein Processing and Cholesterol Metabolism in Cultured Human Fibroblasts

Cécile Mazière, J.-C. Mazière, Nacer-Eddine Houtia, J. Lauga, J. Polonovski
1988 Clinical Chemistry and Laboratory Medicine  
Maziere et al.: Effects of suloctidil oh lipid metabolism in cultured human fibroblasts Summary: Human foetal lung fibroblasts were pretreated for 24 h with the antithrombotic drug, suloctidil (1 to 10μπιο1/1), which induced a dose-dependent increase in LDL binding, uptake and degradation. At 10 μηαοΐ/ΐ suloctidil, the respective increases in these parameters were 40%, 80% and 50%. The same treatment also resulted in increases of 1.5 to 2-fold in the synthesis of sterols, fatty acids and
more » ... glycerols from sodium acetate. In contrast, the esterification of cholesterol with oleic acid was specifically decreased by 35% by 24 h pretreatment of fibroblasts with 10 μπιοΙ/1 suloctidil. A similar decrease of cholesterol esterification was observed in cholesterol-laden fibroblasts. It is suggested that these effects of suloctidil on LDL processing and cholesterol metabolism are related to the amphiphilic characteristics of the drug and to its calciumblocking properties.
doi:10.1515/cclm.1988.26.1.3 fatcat:fnneapvtpzesdhinkzp4r5f6gi